In a trial of patients with hepatitis C genotype 1 without - TopicsExpress



          

In a trial of patients with hepatitis C genotype 1 without cirrhosis and who had not been previously treated, the rate of sustained virologic response was 94% for patients randomized to eight weeks of ledipasvir-sofosbuvir, 93% for eight weeks of ledipasvir-sofosbuvir plus ribavirin, and 95% for 12 weeks of ledipasvir-sofosbuvir. These ION-3 results are being presented at the International Liver Congress today in London, and published on NEJM.org. nej.md/1ilH30S
Posted on: Fri, 11 Apr 2014 13:00:00 +0000

Trending Topics



Recently Viewed Topics




© 2015